Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

CNS Medication Trials

Kentucky

CNS medication trials in Kentucky

19 CNS medication studies are recruiting participants at sites in 5 cities across Kentucky as of November 17, 2026, according to ClinicalTrials.gov.

Call (888) 927-5768
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Kentucky city with a recruiting study

By research area: Migraine (6), Epilepsy (4), Parkinson's Disease (4), ADHD (3), Multiple Sclerosis (2).

Lexington (10), Louisville (6), Bardstown (5), Owensboro (2), Edgewood (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

ADHD: recently updated in Kentucky

Basic details from each study's public record (the 12 most recently updated of 19). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)

    • Phase 3
    • Ages 6 to 11
    • All sexes
    Sponsor
    Axsome Therapeutics, Inc.
    Recruiting in
    Bardstown · Owensboro
    Registry record
    NCT07717879 · updated
  2. Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)

    • Phase 3
    • Ages 12 to 17
    • All sexes
    Sponsor
    Axsome Therapeutics, Inc.
    Recruiting in
    Bardstown · Owensboro
    Registry record
    NCT07717892 · updated

Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Kentucky on ClinicalTrials.gov.

Parkinson's disease: recently updated in Kentucky

  1. A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

    • Phase 2
    • Ages 40 to 80
    • All sexes
    Sponsor
    Neuron23 Inc.
    Recruiting in
    Lexington
    Registry record
    NCT06680830 · updated
  2. A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

    • Phase 2
    • Ages 30 to 80
    • All sexes
    Sponsor
    Appello Pharmaceuticals, Inc.
    Recruiting in
    Lexington
    Registry record
    NCT07432958 · updated
  3. A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Edgewood
    Registry record
    NCT06312176 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Kentucky on ClinicalTrials.gov.

Multiple sclerosis (MS): recently updated in Kentucky

  1. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Lexington
    Registry record
    NCT03816345 · updated

Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Kentucky on ClinicalTrials.gov.

Epilepsy: recently updated in Kentucky

  1. A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

    • Phase 3
    • Ages 12 and older
    • All sexes
    Sponsor
    Xenon Pharmaceuticals Inc.
    Recruiting in
    Lexington
    Registry record
    NCT05667142 · updated
  2. A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

    • Phase 3
    • Ages 2 and older
    • All sexes
    Sponsor
    Epygenix
    Recruiting in
    Louisville
    Registry record
    NCT04462770 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Kentucky on ClinicalTrials.gov.

Migraine: recently updated in Kentucky

  1. A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Recruiting in
    Bardstown · Lexington
    Registry record
    NCT07645924 · updated
  2. A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Recruiting in
    Bardstown · Lexington
    Registry record
    NCT07674654 · updated
  3. A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine

    • Phase 3
    • Ages 12 to 17
    • All sexes
    Sponsor
    H. Lundbeck A/S
    Recruiting in
    Lexington
    Registry record
    NCT04965675 · updated
  4. A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    H. Lundbeck A/S
    Recruiting in
    Lexington
    Registry record
    NCT05164172 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Kentucky on ClinicalTrials.gov.

Ask about studies in Kentucky

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a medication, as each study is coded in the registry.

CNS Medication Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5768

or send a short form

How should we reach you?

Call